Countries citing papers authored by Fred Valeriote
Since
Specialization
Citations
This map shows the geographic impact of Fred Valeriote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Valeriote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Valeriote more than expected).
This network shows the impact of papers produced by Fred Valeriote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Valeriote. The network helps show where Fred Valeriote may publish in the future.
Co-authorship network of co-authors of Fred Valeriote
This figure shows the co-authorship network connecting the top 25 collaborators of Fred Valeriote.
A scholar is included among the top collaborators of Fred Valeriote based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Fred Valeriote. Fred Valeriote is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Li, Yinyin, et al.. (1996). Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.. PubMed. 24(2). 94–100.8 indexed citations
Razek, Aly, Fred Valeriote, & Teresa J. Vietti. (1980). Effect of dose fractionation of daunorubicin on survival of leukemic cells.. PubMed. 40(8 Pt 1). 2835–8.1 indexed citations
13.
Edelstein, Mark, Fred Valeriote, & TJ Vietti. (1978). Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia.. PubMed. 62(4). 547–8.2 indexed citations
14.
Presant, Cary A., Teresa J. Vietti, & Fred Valeriote. (1975). Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(8). 1926–30.7 indexed citations
15.
Vietti, Teresa J., et al.. (1975). Enhancement of the lethal effects of adriamycin (adria) by combining with other agents. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 23. 166–64.2 indexed citations
16.
Medoff, Gerald, Fred Valeriote, Richard G. Lynch, David Schlessinger, & George S. Kobayashi. (1974). Jag orkar inte mer. Cancer Research. 34(5). 974–8.49 indexed citations
17.
Razek, Aly, Fred Valeriote, & Teresa J. Vietti. (1972). Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.. The Mouseion at the JAXlibrary (Jackson Laboratory). 32(7). 1496–500.29 indexed citations
18.
Valeriote, Fred, et al.. (1971). Comparison of the cytotoxicity of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) on normal and leukemic colony-forming cells.. PubMed. 55(1). 43–6.1 indexed citations
Valeriote, Fred, W. Robert Bruce, & B. E. Meeker. (1966). Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells of mice to vinblastine administered in vivo.. PubMed. 36(1). 21–7.25 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.